Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.26 - $0.46 $130 - $230
-500 Reduced 0.33%
150,000 $40.7 Million
Q1 2024

May 15, 2024

BUY
$0.3 - $0.46 $45,150 - $69,230
150,500 New
150,500 $62.2 Million

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.58B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Prairie Wealth Advisors, Inc. Portfolio

Follow Prairie Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairie Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Prairie Wealth Advisors, Inc. with notifications on news.